Single-dose rofecoxib for acute postoperative pain in adults: a quantitative systematic review
Background: Rofecoxib is a cyclo-oxygenase 2 selective inhibitor. This systematic review of rofecoxib in acute pain examined studies of adults of analgesic efficacy over six hours, the amount and quantity of the evidence on extended duration of analgesia, and the quality and quantity of evidence on...
| Main Authors: | , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
BioMed Central
2002
|
| Subjects: |